Exact Mass: 589.1591

dTDP-4-dimethylamino-4,6-dideoxy-5-C-methyl-D-allose

C19H33N3O14P2 (589.1438)

Novclobiocin 104

C29H32ClNO10 (589.1715)

leporizine C

C27H31N3O8S2 (589.1552)

Neoaplaminone sulfate

C26H40BrNO7S (589.1709)

CWHM-12

C26H32BrN5O6 (589.1536)

Pinaverium bromide

C26H41Br2NO4 (589.1402)

C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

RS 39604 hydrochloride

C26H37Cl2N3O6S (589.178)

O-benzyl-L-histidine bis(toluene-p-sulphonate)

C27H31N3O8S2 (589.1552)

Uridylyl-2-5-phospho-guanosine

C19H24N7O13P (589.117)

Exicorilant

C26H23F4N7O3S (589.1519)

C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C183052 - Glucocorticoid Receptor Antagonist C147908 - Hormone Therapy Agent

Rodatristat ethyl

C29H31ClF3N5O3 (589.2067)

C471 - Enzyme Inhibitor

2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-chlorophenyl)methyl]acetamide

C29H27ClF3N3O5 (589.1591)

2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-chlorophenyl)methyl]acetamide

C29H27ClF3N3O5 (589.1591)

2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-[[4-(trifluoromethyl)phenyl]carbamoylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(4-chlorophenyl)methyl]acetamide

C29H27ClF3N3O5 (589.1591)

2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-chlorophenyl)methyl]acetamide

C29H27ClF3N3O5 (589.1591)

2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-chlorophenyl)methyl]acetamide

C29H27ClF3N3O5 (589.1591)

2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-[[4-(trifluoromethyl)phenyl]carbamoylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(4-chlorophenyl)methyl]acetamide

C29H27ClF3N3O5 (589.1591)

2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-[[4-(trifluoromethyl)phenyl]carbamoylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(4-chlorophenyl)methyl]acetamide

C29H27ClF3N3O5 (589.1591)

N-[(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4,4,4-trifluorobutanamide

C27H32Cl2F3N3O4 (589.1722)

N-[(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4,4,4-trifluorobutanamide

C27H32Cl2F3N3O4 (589.1722)

N-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4,4,4-trifluorobutanamide

C27H32Cl2F3N3O4 (589.1722)

N-[(2S,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4,4,4-trifluorobutanamide

C27H32Cl2F3N3O4 (589.1722)

N-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4,4,4-trifluorobutanamide

C27H32Cl2F3N3O4 (589.1722)

N-[(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4,4,4-trifluorobutanamide

C27H32Cl2F3N3O4 (589.1722)

N-[(2S,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4,4,4-trifluorobutanamide

C27H32Cl2F3N3O4 (589.1722)

2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-chlorophenyl)methyl]acetamide

C29H27ClF3N3O5 (589.1591)

Glucuronoxylan D-glucuronate

C21H33O19- (589.1616)

2-amino-4-{[2-({4-[3-(carboxymethyl)-4,6-dihydroxy-2-methoxyphenyl]-3-hydroxy-2-methylbutan-2-yl}sulfanyl)-1-[(carboxymethyl)-C-hydroxycarbonimidoyl]ethyl]-C-hydroxycarbonimidoyl}butanoic acid

C24H35N3O12S (589.1941)

dTDP-4-dimethylamino-4,6-dideoxy-5-C-methyl-L-mannose

C19H33N3O14P2 (589.1438)

6H05 (TFA)

C22H31ClF3N3O4S3 (589.1117)

6H05 TFA is a selective, and allosteric inhibitor of oncogenic mutant K-Ras(G12C). IC50 value: Target: K-Ras G12C 6H05 gives the greatest degree of modification, which allosterically modifies the oncogenic G12C mutant of highly homologous protein H-Ras without affecting wild-type K-Ras [1]. 6H05 can be used as an intermediate for the synthesis of other oncogenic K-Ras(G12C) inhibitors [2].

(1r,8s,13r,14r,17r,26r)-12,13,25,26-tetrahydroxy-8,9,9-trimethyl-1,14-bis(methylsulfanyl)-7-oxa-3,16,18-triazaheptacyclo[14.10.0.0³,¹⁴.0⁴,¹².0⁶,¹⁰.0¹⁷,²⁵.0¹⁹,²⁴]hexacosa-6(10),19,21,23-tetraene-2,11,15-trione

C27H31N3O8S2 (589.1552)

12,13,25,26-tetrahydroxy-8,9,9-trimethyl-1,14-bis(methylsulfanyl)-7-oxa-3,16,18-triazaheptacyclo[14.10.0.0³,¹⁴.0⁴,¹².0⁶,¹⁰.0¹⁷,²⁵.0¹⁹,²⁴]hexacosa-6(10),19,21,23-tetraene-2,11,15-trione

C27H31N3O8S2 (589.1552)

{3-bromo-4-[2-(dimethylamino)ethyl]-5-(11-hydroxy-3,7,11-trimethyl-8-oxododeca-2,9-dien-1-yl)-2-methoxyphenyl}oxidanesulfonic acid

C26H40BrNO7S (589.1709)

{3-bromo-4-[2-(dimethylamino)ethyl]-5-[(2e,7r,9e)-11-hydroxy-3,7,11-trimethyl-8-oxododeca-2,9-dien-1-yl]-2-methoxyphenyl}oxidanesulfonic acid

C26H40BrNO7S (589.1709)